Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis

Neovascular eye diseases including retinopathy of prematurity, diabetic retinopathy and age-related-macular-degeneration are major causes of blindness. Fenofibrate treatment in type 2 diabetes patients reduces progression of diabetic retinopathy independent of its peroxisome proliferator-activated r...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:EBioMedicine
Glavni autori: Gong, Yan, Shao, Zhuo, Fu, Zhongjie, Edin, Matthew L., Sun, Ye, Liegl, Raffael G., Wang, Zhongxiao, Liu, Chi-Hsiu, Burnim, Samuel B., Meng, Steven S., Lih, Fred B., SanGiovanni, John Paul, Zeldin, Darryl C., Hellström, Ann, Smith, Lois E.H.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2016
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5264653/
https://ncbi.nlm.nih.gov/pubmed/27720395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2016.09.025
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items